US Archives - Page 233 of 243 - European Medical Journal

Muscle Mass Improvement after Lung Volume Reduction Interventions in COPD

Lung volume reduction is performed in a highly select population of patients with chronic obstructive pulmonary disease (COPD)…

Advancements in Lung Cancer Screening, Treatment, and Survivorship

Matthew Triplette, Fred Hutchinson Cancer Center and University of Washington, Seattle, USA, delivered an insightful talk…

Electronic Order Set in Latent Tuberculosis Infection Screening for Immunosuppression

Before 2021 in Calgary, Canada, hospitalized inpatient latent tuberculosis infection (LTBI) screening, with a QuantiFERON assay (QFT)…

Sarcoid Versus Tuberculosis, or Both?

Sarcoidosis and tuberculosis (TB) share similar clinical, histological, and radiographical characteristics, and can be difficult to…

Epidemiological Trends in Lung and Bronchus Cancer In Michigan Over 21 Years

As a leading cause of death in the USA, lung and bronchus cancer has claimed the lives of many individuals across the nation…

Genitourinary Tuberculosis Resulting in Hydronephrosis

Genitourinary tuberculosis (GUTB) results from hematogenous spread of chronic latent pulmonary tuberculosis of 5–40 years…

Daptomycin: A Rare Cause of Acute Eosinophilic Pneumonia

Acute eosinophilic pneumonia (AEP) is a rare, potentially fatal lung condition. It can vary in presentation and severity, but classically…

Cystic Fibrosis-Related Endocrinopathies: A Cross-Sectional Study

Advances in the medical and nutritional care of patients with cystic fibrosis (CF) have increased life expectancy in recent years…

Ambulation and Long-Term Oxygen Therapy

Dr. Neil MacIntyre from Duke University covers the ATS Clinical Practice Guideline on Home Oxygen Therapy for Adults with Chronic Lung…

Erratum: Ozanimod Long-Term Safety and Efficacy

In the infographic published under AMJ Neurology, on 30th May 2024, the graphs depicting safety over time titled ‘Malignancy TEAEs’…